LOGIN  |  REGISTER
Amneal Pharmaceuticals
Viking Therapeutics

Addus HomeCare to Participate in March Investor Conferences

March 11, 2025 | Last Trade: US$112.38 2.11 1.91

FRISCO, Texas / Mar 11, 2025 / Business Wire / Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that Dirk Allison, Chairman and Chief Executive Officer, Brad Bickham, President and Chief Operating Officer, and Brian Poff, Executive Vice President and Chief Financial Officer, will participate in the following investor conferences:

  • Oppenheimer 35th Annual Healthcare MedTech & Services Conference on Tuesday, March 18, 2025. Members of the management team will participate in a virtual discussion at 12:00 p.m. Eastern Time / 11:00 a.m. Central Time on Tuesday, March 18, 2025.
  • KeyBanc Capital Markets Healthcare Forum on Wednesday, March 19, 2025. Members of the management team will participate in a virtual fireside chat discussion at 3:00 p.m. Eastern Time / 2:00 p.m. Central Time on Wednesday, March 19, 2025.

In connection with the virtual conferences, there will be a live broadcast and replay of the Company’s presentation available under the Investor Relations section of the Company’s website, www.addus.com. An online replay will also be available on the Company’s website for one month, beginning approximately one hour following the conclusion of the live broadcast.

About Addus HomeCare

Addus HomeCare is a provider of home care services that primarily include personal care services that assist with activities of daily living, as well as hospice and home health services. Addus HomeCare’s consumers are primarily persons who, without these services, are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Addus HomeCare’s payor clients include federal, state, and local governmental agencies, managed care organizations, commercial insurers, and private individuals. Addus HomeCare currently provides home care services to approximately 62,000 consumers through 257 locations across 23 states. For more information, please visit www.addus.com.

Astria Therapeutics

Stock Quote

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page